Product Information
CHEST CONGEST RLF 400 MG TAB is a generic product labeled by Cardinal Health, priced at $0.0656 per EA under NDC 70000005501. Its NADAC has been published 261 times since Oct 6, 2021.
Strength
400 mg/1
Manufacturer
Cardinal HealthNDC
70000005501
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
GUAIFENESINApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
9/1/2020
Pharmacological Classes
Price Statistics
The NADAC for CHEST CONGEST RLF 400 MG TAB has been published 261 times since Oct 6, 2021, and over the history we have for it it has declined 4.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0656 per EA |
|---|---|
| All-time high | $0.0744 (Nov 13, 2024) |
| All-time low | $0.0560 (Apr 19, 2023) |
| 52-week high | $0.0683 |
| 52-week low | $0.0653 |
| Median price | $0.0672 |
| Average price | $0.0670 |
| Largest weekly change | +13.5% (May 17, 2023) |
| Weeks tracked | 261 |
| Tracking since | Oct 6, 2021 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Cardinal Health manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Guaifenesin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Expectorant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CHEST CONGEST RLF 400 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for CHEST CONGEST RLF 400 MG TAB, manufactured by Cardinal Health, is $0.0656 per EA (NDC 70000005501), effective Sep 30, 2026.
How has the price of CHEST CONGEST RLF 400 MG TAB changed over time?
Over the history we have for it, the NADAC for CHEST CONGEST RLF 400 MG TAB has declined 4.5%. It has been tracked across 261 weekly CMS publications since Oct 6, 2021.
What are the highest and lowest recorded NADAC prices for CHEST CONGEST RLF 400 MG TAB?
Since Oct 6, 2021, the NADAC for CHEST CONGEST RLF 400 MG TAB has ranged from a low of $0.0560 (Apr 19, 2023) to a high of $0.0744 (Nov 13, 2024), with a median of $0.0672 per EA.
Are there cheaper alternatives to CHEST CONGEST RLF 400 MG TAB?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CHEST CONGEST RLF 400 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures CHEST CONGEST RLF 400 MG TAB?
CHEST CONGEST RLF 400 MG TAB (NDC 70000005501) is labeled by Cardinal Health, and CMS classifies it as a generic product.